10x Genomics, Inc. is a medical - healthcare information services company in the healthcare sector trading on NASDAQ, led by CEO Serge Saxonov, with a market cap of $2.9B.
Common questions about 10x Genomics, Inc.
10x Genomics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026 after market close. Analysts estimate revenue of $146.4M.
10x Genomics, Inc. has approximately 1,259 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.